Monnens LA - Search Results

1

Levtchenko EN, Wilmer M, de Graaf-Hess AC, van den Heuvel LP, Blom H, Monnens LA. Levtchenko EN, et al. Among authors: monnens la. Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8. Ned Tijdschr Geneeskd. 2004. PMID: 15042893 Review. Dutch.

2

Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.

Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ. Levtchenko EN, et al. Among authors: monnens la. Pediatr Nephrol. 2006 Jan;21(1):110-3. doi: 10.1007/s00467-005-2052-0. Epub 2005 Oct 27. Pediatr Nephrol. 2006. PMID: 16252107

3

Cystine dimethylester model of cystinosis: still reliable?

Wilmer MJ, Willems PH, Verkaart S, Visch HJ, de Graaf-Hess A, Blom HJ, Monnens LA, van den Heuvel LP, Levtchenko EN. Wilmer MJ, et al. Among authors: monnens la. Pediatr Res. 2007 Aug;62(2):151-5. doi: 10.1203/PDR.0b013e31809fd9a7. Pediatr Res. 2007. PMID: 17597653

4

Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis.

Wilmer MJ, Christensen EI, van den Heuvel LP, Monnens LA, Levtchenko EN. Wilmer MJ, et al. Among authors: monnens la. Am J Kidney Dis. 2008 Jun;51(6):893-903. doi: 10.1053/j.ajkd.2008.03.010. Epub 2008 May 2. Am J Kidney Dis. 2008. PMID: 18455850

5

Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy.

Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H. Levtchenko E, et al. Clin Chem. 2004 Sep;50(9):1686-8. doi: 10.1373/clinchem.2004.031872. Clin Chem. 2004. PMID: 15331510 No abstract available.

6

Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.

Levtchenko EN, de Graaf-Hess A, Blom HJ, Monnens LA. Levtchenko EN, et al. Among authors: monnens la. Clin Nephrol. 2002 May;57(5):349-51. doi: 10.5414/cnp57349. Clin Nephrol. 2002. PMID: 12036193

7

[From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system].

Geelen JM, Klasen IS, van den Heuvel LP, Monnens LA. Geelen JM, et al. Among authors: monnens la. Ned Tijdschr Geneeskd. 2007 Jan 20;151(3):185-8. Ned Tijdschr Geneeskd. 2007. PMID: 17288344 Review. Dutch.

8

[From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids].

Levtchenko EN, Deinum J, Knoers NV, Hermus AR, Monnens LA, Lenders JW. Levtchenko EN, et al. Among authors: monnens la. Ned Tijdschr Geneeskd. 2007 Mar 24;151(12):692-4. Ned Tijdschr Geneeskd. 2007. PMID: 17447595 Review. Dutch.

9

[From gene to disease; Dent's disease caused by abnormalities in the CLCN5 and OCRL1 genes].

Levtchenko EN, Monnens LA, Bökenkamp A, Knoers NV. Levtchenko EN, et al. Among authors: monnens la. Ned Tijdschr Geneeskd. 2007 Oct 27;151(43):2377-80. Ned Tijdschr Geneeskd. 2007. PMID: 18019214 Review. Dutch.

10

Follow-up and treatment of adults with cystinosis in the Netherlands.

Geelen JM, Monnens LA, Levtchenko EN. Geelen JM, et al. Among authors: monnens la. Nephrol Dial Transplant. 2002 Oct;17(10):1766-70. doi: 10.1093/ndt/17.10.1766. Nephrol Dial Transplant. 2002. PMID: 12270982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters